Basic Information
RNALocate ID: | RLID:11004158 |
RNA Symbol: | hsa-miR-877-5p |
Localization: | Extracellular vesicle |
RNA Information
RNA Name: | hsa-miR-877 |
RNA ID: | miRBase:MIMAT0004949 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 22849433 |
Tissue/Cell Line: | HEK-293T cells |
Method: | Next-generation RNA sequencing |
Description: | The total numbers of reads >15 bp matching each miRNA were calculated. These values were then normalized to number of reads per million mapped (RPMM) in each library, to enable direct comparison of expression levels. As a measure of the relative levels of expression of individual miRNAs in cells and EVs, the log (base two) of the ratio of the read number in EVs over that in cells was calculated (log2 (EV/cell)). The miRNA expression data for cells and EVs is presented in Additional file 1: Table S1. Data are collected from Table S1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002702 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002703 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002704 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11004154 | Exosome | Primary T lymphocytes | 24356509 |
RLID:11004155 | Exosome | Pooled sera | 27278097 |
RLID:11004156 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
RLID:11004157 | Exosome | K562 cells | 24460325 |
RLID:11004159 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000218 | Exosome | Lymphoma tissue | |
RLID-D:11000725 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-877-5p | Oral squamous cell carcinoma | MNDR-E-MI-70048 |
MNDR | hsa-miR-877-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-70049 |
MNDR | hsa-miR-877-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-70050 |
MNDR | hsa-miR-877-5p | Lymphoma | MNDR-E-MI-70051 |
MNDR | hsa-miR-877-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-70052 |
MNDR | hsa-miR-877-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-70053 |
MNDR | hsa-miR-877-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-70054 |
MNDR | hsa-miR-877-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-70055 |
MNDR | hsa-miR-877-5p | Her2-receptor positive breast cancer | MNDR-E-MI-70056 |
MNDR | hsa-miR-877-5p | Breast cancer luminal | MNDR-E-MI-70057 |
MNDR | hsa-miR-877-5p | Prostate cancer | MNDR-E-MI-70058 |
MNDR | hsa-miR-877-5p | Gastric cancer | MNDR-E-MI-70059 |
MNDR | hsa-miR-877-5p | Alzheimer disease | MNDR-E-MI-70060 |
MNDR | hsa-miR-877-5p | Esophageal carcinoma | MNDR-E-MI-70061 |
MNDR | hsa-miR-877-5p | Huntington disease | MNDR-E-MI-70062 |
MNDR | hsa-miR-877-5p | Chorea | MNDR-E-MI-70063 |
MNDR | hsa-miR-877-5p | Cardiovascular disease | MNDR-E-MI-70064 |
MNDR | hsa-miR-877-5p | Lung cancer | MNDR-E-MI-70065 |
MNDR | hsa-miR-877-5p | Parkinson disease | MNDR-E-MI-70066 |
MNDR | hsa-miR-877-5p | Basal-like breast cancer | MNDR-E-MI-70067 |
MNDR | hsa-miR-877-5p | Pancreatic cancer | MNDR-E-MI-70068 |
MNDR | hsa-miR-877-5p | Melanoma | MNDR-E-MI-70069 |
MNDR | hsa-miR-877-5p | Rectum adenocarcinoma | MNDR-E-MI-70070 |
MNDR | hsa-miR-877-5p | Nephroblastoma | MNDR-E-MI-70071 |
MNDR | hsa-miR-877-5p | Colon cancer | MNDR-E-MI-70072 |
MNDR | hsa-miR-877-5p | Colon adenocarcinoma | MNDR-E-MI-70073 |
MNDR | hsa-miR-877-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-70074 |
MNDR | hsa-miR-877-5p | Familial ovarian cancer | MNDR-E-MI-70075 |
MNDR | hsa-miR-877-5p | Carcinoma ductal breast | MNDR-E-MI-70076 |
MNDR | hsa-miR-877-5p | Glioblastoma | MNDR-E-MI-70077 |
MNDR | hsa-miR-877-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-70078 |
MNDR | hsa-miR-877-5p | Chordoma | MNDR-E-MI-70079 |
MNDR | hsa-miR-877-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-70080 |
MNDR | hsa-miR-877-5p | Osteosarcoma | MNDR-E-MI-70081 |
MNDR | hsa-miR-877-5p | Breast carcinoma | MNDR-E-MI-70082 |
MNDR | hsa-miR-877-5p | Liver cancer | MNDR-E-MI-70083 |
MNDR | hsa-miR-877-5p | Gastric adenocarcinoma | MNDR-E-MI-70084 |
MNDR | hsa-miR-877-5p | Lung squamous cell carcinoma | MNDR-E-MI-70085 |
MNDR | hsa-miR-877-5p | Lung adenocarcinoma | MNDR-E-MI-70086 |
MNDR | hsa-miR-877-5p | Thyroid carcinoma | MNDR-E-MI-70087 |
MNDR | hsa-miR-877-5p | Ovarian carcinoma | MNDR-E-MI-70088 |
MNDR | hsa-miR-877-5p | Bladder urothelial carcinoma | MNDR-E-MI-70089 |
MNDR | hsa-miR-877-5p | Pancreatic adenocarcinoma | MNDR-E-MI-70090 |
MNDR | hsa-miR-877-5p | Esophageal cancer | MNDR-E-MI-70091 |
MNDR | hsa-miR-877-5p | Lung small cell carcinoma | MNDR-E-MI-70092 |
MNDR | hsa-miR-877-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-70093 |
MNDR | hsa-miR-877-5p | T acute lymphoblastic leukemia | MNDR-E-MI-70094 |
MNDR | hsa-miR-877-5p | Acute t cell leukemia | MNDR-E-MI-70095 |
MNDR | hsa-miR-877-5p | Adenoma | MNDR-E-MI-70096 |
MNDR | hsa-miR-877-5p | Breast invasive carcinoma | MNDR-E-MI-70097 |
MNDR | hsa-miR-877-5p | Hepatocellular carcinoma | MNDR-E-MI-70098 |
MNDR | hsa-miR-877-5p | Familiar ovarian carcinoma | MNDR-E-MI-70099 |
MNDR | hsa-miR-877-5p | Rheumatoid arthritis | MNDR-E-MI-70100 |
MNDR | hsa-miR-877-5p | Malignant pleural mesothelioma | MNDR-E-MI-70101 |
MNDR | hsa-miR-877-5p | Hodgkin lymphoma | MNDR-E-MI-70102 |
MNDR | hsa-miR-877-5p | Colorectal cancer | MNDR-E-MI-70103 |
MNDR | hsa-miR-877-5p | Nasopharynx carcinoma | MNDR-E-MI-70104 |
MNDR | hsa-miR-877-5p | Nasopharyngeal cancer | MNDR-E-MI-70105 |
MNDR | hsa-miR-877-5p | Stroke lacunar | MNDR-E-MI-70106 |
MNDR | hsa-miR-877-5p | Breast cancer her3+ negative | MNDR-E-MI-70107 |
MNDR | hsa-miR-877-5p | Tubulovillous adenoma | MNDR-E-MI-70108 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | EEF2K | Homo sapiens | RR00484494 |
TOP